We are live on ! Find out more
RFM

Royal Fund Management Portfolio holdings

AUM $1.2B
1-Year Est. Return 32.21%
This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+32.21%
3 Year Est. Return
+92.42%
5 Year Est. Return
+97.01%
10 Year Est. Return
–
AUM
$359M
AUM Growth
+$21.3M
Cap. Flow
+$16.7M
Cap. Flow %
4.66%
Top 10 Hldgs %
27.69%
Holding
711
New
115
Increased
178
Reduced
104
Closed
38

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$4.4M
2
UPS icon
United Parcel Service
UPS
+$4.14M
3
ELD icon
WisdomTree Emerging Markets Local Debt Fund
ELD
+$2.5M
4
JCI icon
Johnson Controls International
JCI
+$2.41M
5
ABBV icon
AbbVie
ABBV
+$1.97M

Top Sells

Rank Stock Value
1
SPYV icon
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
+$3.54M
2
PFE icon
Pfizer
PFE
+$3.19M
3
WM icon
Waste Management
WM
+$3.18M
4
T icon
AT&T
T
+$2.83M
5
SPTL icon
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
+$2.83M

Sector Composition

Rank Sector Weight
1 Technology 9.92%
2 Healthcare 8.24%
3 Consumer Staples 7.22%
4 Energy 6.62%
5 Consumer Discretionary 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TONX
676
TON Strategy Co
TONX
$168M
– –
0
– –
VMBS icon
677
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
– –
-64
Closed -$3K
WDC icon
678
Western Digital
WDC
$188B
$0 ﹤0.01%
+12
New +$512
WRAP icon
679
Wrap Technologies
WRAP
$103M
$0 ﹤0.01%
100
– –
WSO icon
680
Watsco Inc
WSO
$12.7B
$0 ﹤0.01%
+3
New +$486
XXII
681
22nd Century Group
XXII
$1.38M
– –
0
– –
IRD
682
Opus Genetics
IRD
$306M
$0 ﹤0.01%
1
– –
TVRD
683
Tvardi Therapeutics
TVRD
$19.7M
$0 ﹤0.01%
+1
New +$831
VIVS
684
VivoSim Labs
VIVS
$1.2M
$0 ﹤0.01%
4
– –
ORGS
685
DELISTED
Orgenesis Inc. Common Stock
ORGS
$0 ﹤0.01%
4
– –
NS
686
DELISTED
NuStar Energy L.P.
NS
– –
-400
Closed -$10K
AEL
687
DELISTED
American Equity Investment Life Holding Company
AEL
– –
-1,383
Closed -$37K
MDC
688
DELISTED
M.D.C. Holdings, Inc.
MDC
$0 ﹤0.01%
1
– –
NEPT
689
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
– –
0
– –
LTHM
690
DELISTED
Livent Corporation
LTHM
$0 ﹤0.01%
93
– –
PACW
691
DELISTED
PacWest Bancorp
PACW
$0 ﹤0.01%
+15
New +$542
UMPQ
692
DELISTED
Umpqua Holdings Corp
UMPQ
$0 ﹤0.01%
+33
New +$542
NBEV
693
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$0 ﹤0.01%
324
+224
+224% +$791
CLDR
694
DELISTED
Cloudera, Inc.
CLDR
– –
-200
Closed -$1K
MXIM
695
DELISTED
Maxim Integrated Products
MXIM
$0 ﹤0.01%
+10
New +$579
PRSP
696
DELISTED
Perspecta Inc. Common Stock
PRSP
– –
-2
Closed –
APHA
697
DELISTED
Aphria Inc. Common Shares
APHA
$0 ﹤0.01%
98
– –
ANH
698
DELISTED
Anworth Mortgage Asset Corporation
ANH
$0 ﹤0.01%
20
– –
FIT
699
DELISTED
Fitbit, Inc. Class A common stock
FIT
$0 ﹤0.01%
10
– –
MNK
700
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$0 ﹤0.01%
18
– –
25 26 27
28
29

Similar funds

FCCPG
FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return
AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CA
Callahan Advisors Houston, Texas $1.2B AUM 22.34% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
SGDR
SPX Gestao de Recursos Rio De Janeiro, Brazil $1.2B AUM 59.05% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

Royal Fund Management's Q3 2019 Portfolio in Review

As of Q3 2019, Royal Fund Management held 711 positions worth $359M, up 6.3% from $337M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Royal Fund Management deployed $16.7M of net new capital in Q3 2019, opening 115 new positions and adding to 178 existing holdings. Its largest new stake was US Bancorp: 23,398 shares worth $1.29M.

By sector, the portfolio is most concentrated in Technology at 9.9% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 Value ETF, an estimated $3.54M trimmed.

  • Royal Fund Management's largest Q3 2019 buy was US Bancorp: 23,398 shares worth $1.29M.
  • Royal Fund Management added most to Bristol-Myers Squibb in Q3 2019, an estimated $4.4M increase.
  • Royal Fund Management's biggest Q3 2019 reduction was State Street SPDR Portfolio S&P 500 Value ETF, cutting an estimated $3.54M.
  • Royal Fund Management fully exited Kraft Heinz in Q3 2019, selling an estimated $755K.
  • Royal Fund Management's ten largest holdings make up 28% of its $359M portfolio in Q3 2019.
  • Royal Fund Management opened 115 new positions and closed 38 in Q3 2019.
  • Royal Fund Management's portfolio value rose 6.3% quarter-over-quarter to $359M.

Based on Royal Fund Management's 13F filing for Q3 2019, filed 8 May 2020.